DGAT1 and amyotrophic lateral sclerosis: Patients with mutations in TARDBP exhibit similar phenotypes, which are reversed with DGAT inhibition, suggesting that lipid pathways, specifically TG metabolism may be dysregulated in TARDBP-driven ALS.